Home/News/VOGXNewsVOGX ▼ -0.7% - Vogenx, Inc.$VOGXCP $16.05▲ -0.7%Oct 15, 2026 · ThinkSabio BlogVOGX ▼ -0.7% - Vogenx, Inc. $VOGX - Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia 15-OCT-2026 04:36 PM ET Share this post🔗Copy LinkMore filings for $VOGXVOGX ▼ -0.3% - Vogenx, Inc.Sep 22, 2026View full $VOGX filing history →💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore News